We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Securities Fraud Suit Follows Pfizer's Drug Collapse

Law360 (December 8, 2006, 12:00 AM EST) -- A class action law firm has filed a securities fraud lawsuit against Pfizer Inc., just days after the drug giant scrapped its highly anticipated cholesterol drug torcetrapib, which took 15 years and $1 billion to develop.

New York firm Schoengold Sporn Laitman & Lometti filed the proposed class action lawsuit on Dec. 6 in the U.S. District Court for the Southern District of New York.

The complaint, which seeks $10 million, was filed on behalf of a New York union, the Uniformed Sanitationmen's Association Local 831....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.